Medline Submits Draft Registration for Initial Public Offering
The company announced a confidential submission of a draft registration statement for the proposed initial public offering of its common stock

NORTHFIELD, Illinois—Medline Inc., a private manufacturer and distributor of medical supply products, announced it has submitted a draft registration statement on form S-1 to the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering (IPO) of its common stock. The company said the number of shares to be offered and the price range for the proposed offering have yet to be determined.

Belluscura Starts Trading on U.K. Alternative Investment Market

LONDON, U.K. & PLANO, Texas (May 28, 2021)—Belluscura plc, a medical device developer focused on lightweight and portable oxygen enrichment technology, announced that admission to trading on the Alternative Investment Market (AIM) will take place, and dealings will commence at 8:00 a.m. today under the ticker BELL and ISIN GB00BD3B8Z11. AIM is a sub-market of the London Stock Exchange.

IMAC Holdings Announces Closing of Public Offering

BRENTWOOD, Tenn. (March 31, 202)—IMAC Holdings, Inc., a provider of medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, closed its previously announced underwritten public offering of 10,625,000 shares of common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million.

InnovAge Announces IPO

DENVER (March 4, 2021)—InnovAge Holding Corp. announced the pricing of its initial public offering of 16,666,667 shares of its common stock at a price to the public of $21.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol “INNV” on March 4, 2021, and the offering is expected to close on March 8, 2021, subject to customary closing conditions.


Apria Announces IPO

INDIANAPOLIS (February 10, 2021—Apria, Inc. (the company or Apria) announced today the pricing of its initial public offering of 7,500,000 shares of its common stock at a price to the public of $20.00 per share. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock. The shares are expected to begin trading on the Nasdaq Global Select Market on Feb.